VR Logo

Divi's Laboratories Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1990

Chairman: Ramesh BV Nimmagadda

Managing Director: Murali K Divi

Group: Divis Labs

Listing: NSE: DIVISLAB, BSE: 532488

Headquarters: Hyderabad, Telangana

Website: www.divislaboratories.com

Key Facts

Market cap: R 57,454.04 Cr

Revenue (TTM): R 5,394.42 Cr

Earnings (TTM): R 1,376.54 Cr

Cash: R 1,513.60 Cr

Total Debt: R 105.60 Cr

Promoters' ownership: 51.97%

Liquidity: High

52 Week range: R 1,466.00 - 2,537.95

Face value: R2.00

Shares outstanding: 26,54,68,580

10 Years Aggregate:

  • CFO: 6,815.70 Cr
  • EBITDA: 10,596.29 Cr
  • Net Profit: 7,945.70 Cr

Stock Performance

Time Period Divi's Laboratories S&P BSE Sensex S&P BSE Healthcare
YTD17.21-11.9421.85
1 month-10.345.702.17
3 months-0.2521.5316.68
1 Year37.31-6.1830.34
3 Years46.985.014.38
5 Years18.025.58-0.60
10 Years18.977.4811.02
As on 08-Jul-2020
Year Divi's Laboratories S&P BSE Sensex S&P BSE Healthcare
201925.1014.38-3.55
201834.775.87-5.89
201740.1527.910.49
2016-32.581.95-12.88
201532.33-5.0315.06
201440.4429.8947.43
201311.218.9822.55